2m 2m 2m 2m 2m 2m 2m
EQUILLIUM (EQ)
NASDAQ
$2.86-$0.02 (-0.87%)
Price as of Jul 14, 2026 6:35 AM EDT- $182.1MMarket Cap
- 685.60%1-Year Change
- BiotechnologyIndustry
EQUILLIUM (EQ)
$2.86-$0.02 (-0.87%)
EQ | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $2.88 | ||
Change | -$0.03 (-1.03%) | ||
Open | $3.02 | ||
High | $3.12 | ||
Low | $2.83 | ||
Previous Close | $2.91 | ||
Volume | 1,420,587 | ||
30-Day Average Volume | 1,035,905 | ||
1-Week Change | 3.97% | ||
1-Month Change | 2.49% | ||
1-Year Change | 685.60% | ||
3-Year Change | 232.95% | ||
5-Year Change | -50.77% | ||
Fundamentals | |||
Shares Outstanding | 63.2M | ||
Total Assets | $63.1M | ||
Market Cap | $182.1M | ||
Enterprise Value | $120.8M | ||
Period: QTR TTM FY | |||
Revenue | N/A | ||
Net Income | -$5.3M | ||
Free Cash Flow | -$4.3M | ||
EBIT | -$5.3M | ||
EBITDA | -$5.3M | ||
Net Working Capital | $58.9M | ||
EPS | -$0.06 | ||
Enterprise Value/EBITDA | -23 | ||
Enterprise Value/Revenue | N/A | ||
P/B | 3 | ||
P/E | -48 | ||
PEG | 1 | ||
Price/Free Cash Flow | -42 | ||
Price/Operating Cash Flow | -42 | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | N/A | ||
Trailing Annual Dividend Yield | N/A | ||
Ex-Dividend Date | 06/12/2009 | ||
Last Split Factor | N/A | ||
Last Split Date | N/A | ||
Earnings & Revenue